大数据时代肿瘤心脏病学的机遇和挑战  

Big Data in Cardio-oncology:Challenges and Opportunities

作　　者：王阿曼[1] 夏云龙[2] 

机构地区：[1]大连医科大学附属第一医院肿瘤科,辽宁大连116011 [2]大连医科大学附属第一医院心内科,辽宁大连116011

出　　处：《心血管病学进展》2018年第2期135-138,共4页Advances in Cardiovascular Diseases

摘　　要：大数据的应用使得疾病的诊疗模式得到极大的进步。作为一门新兴学科,肿瘤心脏病学研究刚刚起步。广泛的数据共享和大数据研究有助于研究抗肿瘤治疗心脏毒性的发生率和发生机制,并对不断出现的新型靶向药物的药物警戒性数据的获取提供支持。大数据方法的应用为肿瘤心脏病学的发展带来了机遇和挑战。The application of big data has changed the pattern of diseases,diagnosis and treatment. As a relatively new discipline, cardio-oncology research has just started. Creating a broad coalition of data sharing can provide insights into the incidence of cardiotoxicity and stimulate research into the underlying mechanisms. A pharmacovigilant approach using large data sets can help characterize cardiovascu- 1 虹 toxicities of the rapidly expanding amiamentarium of targeted 出erapies. Despite its chaEenges, a “ big data” approach offere a urdque op- portunily within the field of cardio-oncology.

关 键 词：大数据 肿瘤心脏病学 心脏毒性 药物警戒 

分 类 号：R732[医药卫生—肿瘤]